Impact BioMedical, Inc.
IBO US45259L2051
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Dss, Inc. O |
0.54 USD |
45,400 Sold |
24,530 USD |
22/05/2025 | 27/05/2025 |
Dss, Inc. O |
0.54 USD |
45,400 Sold |
24,530 USD |
22/05/2025 | 27/05/2025 |
Dss, Inc. O |
0.55 USD |
115,600 Sold |
63,476 USD |
22/05/2025 | 22/05/2025 |
Dss, Inc. O |
0.55 USD |
115,600 Sold |
63,476 USD |
22/05/2025 | 22/05/2025 |
Dss, Inc. O |
0.95 USD |
890,800 Sold |
845,013 USD |
04/04/2025 | 04/04/2025 |
Chan Heng Fai Ambrose O |
0.50 USD |
351,555 Sold |
174,020 USD |
03/04/2025 | 03/04/2025 |
Dss, Inc. O |
2.50 USD |
47,681 Sold |
119,255 USD |
21/03/2025 | 27/03/2025 |
Dss, Inc. O |
3.15 USD |
9,858 Sold |
31,053 USD |
21/03/2025 | 26/03/2025 |
Dss, Inc. O |
3.13 USD |
48,281 Sold |
151,081 USD |
21/03/2025 | 26/03/2025 |
Dss, Inc. O |
3.15 USD |
9,858 Sold |
31,053 USD |
21/03/2025 | 26/03/2025 |